Methylphenidate Exerts Dose-Dependent Effects on Glutamate Receptors and Behaviors
Open accessThe DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Abstract
Background Methylphenidate (MPH), a psychostimulant drug for the treatment of attention-deficit hyperactivity disorder (ADHD), produces the effects of increasing alertness and improving attention, while its misuse has been associated with an increased risk of aggression and psychosis. In this study, we sought to determine the molecular mechanism underlying the complex actions of MPH. Methods Adolescent (4-week-old) rats were given one injection of MPH at different doses. The impact of MPH on glutamatergic signaling in pyramidal neurons of prefrontal cortex (PFC) was measured. MPH-induced behavioral changes were also examined in parallel. Results We found that administration of low-dose (0.5 mg/kg) MPH selectively potentiated NMDAR-mediated excitatory synaptic currents (EPSCs) via adrenergic receptor activation, while the high-dose (10 mg/kg) MPH suppressed both NMDAR- and AMPAR-EPSCs. The dual effects of MPH on EPSCs were associated with bi-directional changes in the surface level of glutamate receptor subunits. Behavioral tests also indicated that low-dose MPH facilitated the PFC-mediated temporal order recognition memory (TORM) and attention, while animals injected with high-dose MPH exhibited significantly elevated locomotive activity. Inhibiting the function of SNAP-25, a key SNARE proteins involved in NMDAR exocytosis, blocked the increase of NMDAR-EPSC by low-dose MPH. In animals exposed to repeated stress, administration of low-dose MPH effectively restored NMDAR function and TORM via a mechanism dependent on SNAP-25. Conclusions Our results have provided a potential mechanism underlying the cognitive enhancing effects of low-dose MPH, as well as the psychosis-inducing effects of high-dose MPH.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cellular basis of working memory
Goldman-Rakic, P. S. (1995) · Neuron · doi:10.1016/0896-6273(95)90304-6 · Cited by 2,663
Medial Frontal Cortex Mediates Perceptual Attentional Set Shifting in the Rat
Birrell, J. M., & Brown, V. J. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-11-04320.2000 · Cited by 1,421 · cited 2×
“In the test of perceptual attentional set-shifting, an aspect of attention mediated by medial frontal cortex (28), rats injected with low-dose MPH exhibited selective improvement in the extradimensional shift, taking fewer trials”
BackgroundMethodPrefrontal executive and cognitive functions in rodents: neural and neurochemical substrates
Dalley, J. W., Cardinal, R. N., & Robbins, T. W. (2004) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2004.09.006 · Cited by 1,329 · cited 1×
“003 sustained attention, inhibitory response control, and cognitive flexibility (11,12).”
BackgroundToward systems neuroscience of ADHD: a meta-analysis of 55 fMRI studies
Cortese, S., Kelly, C., Chabernaud, C., Proal, E., Di Martino, A., Milham, M. P., & Castellanos, F. X. (2012) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2012.11101521 · Cited by 1,067 · cited 3×
“Given that children with ADHD exhibit prefrontal hypoactivity (15,16), the elevated NMDAR function by low-dose MPH might underlie its beneficial effects on memory, attention, and other cognitive aspects.”
BackgroundListon, C., Miller, M. M., Goldwater, D. S., Radley, J. J., Rocher, A. B., Hof, P. R., Morrison, J. H., & McEwen, B. S. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.1184-06.2006 · Cited by 968
Barker, G. R. I., Bird, F., Alexander, V., & Warburton, E. C. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.5289-06.2007 · Cited by 691
A peptide inhibitor of c-Jun N-terminal kinase protects against excitotoxicity and cerebral ischemia
Borsello, T., Clarke, P. G. H., Hirt, L., Vercelli, A., Repici, M., Schorderet, D. F., Bogousslavsky, J., & Bonny, C. (2003) · Nature Medicine · doi:10.1038/nm911 · Cited by 658
Berridge, C. W., Devilbiss, D. M., Andrzejewski, M. E., Arnsten, A. F. T., Kelley, A. E., Schmeichel, B., Hamilton, C., & Spencer, R. C. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.04.022 · Cited by 617 · cited 6×
“Therapeutic dose of MPH effectively improves cognitive function and reduces hyperactivity in individuals with ADHD (2) as well as normal human subjects and animals (3,4).”
BackgroundResultInfluentialThe prefrontal cortex as a key target of the maladaptive response to stress
Cerqueira, J. J., Mailliet, F., Almeida, O. F. X., Jay, T. M., & Sousa, N. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.4372-06.2007 · Cited by 599 · cited 1×
“Previous studies have found that repeated stress suppresses PFC glutamatergic signaling, resulting in cognitive impairment (24,26,59,60).”
BackgroundAcute stress enhances glutamatergic transmission in prefrontal cortex and facilitates working memory
Yuen, E. Y., Liu, W., Karatsoreos, I. N., Feng, J., McEwen, B. S., & Yan, Z. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0906791106 · Cited by 481 · cited 2×
“Electrophysiologic Recordings Recordings of evoked synaptic currents in prefrontal cortical slices used standard whole-cell voltage-clamp technique as we described previously (23,24).”
MethodSelf-citation
Research works printed but not linked: 43
- Biederman, 2005, Attention-deficit/hyperactivity disorder: A selective overview, Biol Psychiatry, 57, 1215, 10.1016/j.biopsych.2004.10.020 · DOI · Paper page
- Smith, 2011, Are prescription stimulants “smart pills”? The epidemiology and cognitive neuroscience of prescription stimulant use by normal healthy individuals, Psychol Bull, 137, 717, 10.1037/a0023825 · DOI · Paper page
- Klein-Schwartz, 2002, Abuse and toxicity of methylphenidate, Curr Opin Pediatr, 14, 219, 10.1097/00008480-200204000-00013 · DOI · Paper page
- Gerasimov, 2000, Comparison between intraperitoneal and oral methylphenidate administration: A microdialysis and locomotor activity study, J Pharmacol Exp Ther, 295, 51, 10.1016/S0022-3565(24)38868-8 · DOI · Paper page
- Wiley, 2009, Kappa-opioid system regulates the long-lasting behavioral adaptations induced by early-life exposure to methylphenidate, Neuropsychopharmacology, 34, 1339, 10.1038/npp.2008.188 · DOI · Paper page
- Warren, 2011, Juvenile administration of concomitant methylphenidate and fluoxetine alters behavioral reactivity to reward- and mood-related stimuli and disrupts ventral tegmental area gene expression in adulthood, J Neurosci, 31, 10347, 10.1523/JNEUROSCI.1470-11.2011 · DOI · Paper page
- Spencer, 2006, PET study examining pharmacokinetics, detection and likeability, and dopamine transporter receptor occupancy of short- and long-acting oral methylphenidate, Am J Psychiatry, 163, 387, 10.1176/appi.ajp.163.3.387 · DOI · Paper page
- Shaw, 2007, Attention-deficit/hyperactivity disorder is characterized by a delay in cortical maturation, Proc Natl Acad Sci U S A, 104, 19649, 10.1073/pnas.0707741104 · DOI · Paper page
- Arnsten, 2006, Fundamentals of attention-deficit/hyperactivity disorder: Circuits and pathways, J Clin Psychiatry, 67, 7
- Fernández, 2009, Complexity analysis of spontaneous brain activity in attention-deficit/hyperactivity disorder: Diagnostic implications, Biol Psychiatry, 65, 571, 10.1016/j.biopsych.2008.10.046 · DOI
- Lisman, 1998, A role for NMDA-receptor channels in working memory, Nat Neurosci, 1, 273, 10.1038/1086 · DOI · Paper page
- Kantrowitz, 2012, Glutamatergic transmission in schizophrenia: From basic research to clinical practice, Curr Opin Psychiatry, 25, 96, 10.1097/YCO.0b013e32835035b2 · DOI · Paper page
- Spear, 2000, The adolescent brain and age-related behavioral manifestations, Neurosci Biobehav Rev, 24, 417, 10.1016/S0149-7634(00)00014-2 · DOI · Paper page
- Yuen, 2011, Mechanisms for acute stress-induced enhancement of glutamatergic transmission and working memory, Mol Psychiatry, 16, 156, 10.1038/mp.2010.50 · DOI · Paper page
- Yuen, 2012, Repeated stress causes cognitive impairment by suppressing glutamate receptor expression and function in prefrontal cortex, Neuron, 73, 962, 10.1016/j.neuron.2011.12.033 · DOI · Paper page
- Lou, 2012, Reduced release probability prevents vesicle depletion and transmission failure at dynamin mutant synapses, Proc Natl Acad Sci U S A, 109, 515, 10.1073/pnas.1121626109 · DOI · Paper page
- Wei, 2013, Estrogen protects against the detrimental effects of repeated stress on glutamatergic transmission and cognition [published online ahead of print Jul 9], Mol Psychiatry
- Manabe, 1993, Modulation of synaptic transmission and long-term potentiation: Effects on paired pulse facilitation and EPSC variance in the CA1 region of the hippocampus, J Neurophysiol, 70, 1451, 10.1152/jn.1993.70.4.1451 · DOI · Paper page
- Yang, 2006, Acute and chronic methylphenidate dose-response assessment on three adolescent male rat strains, Brain Res Bull, 71, 301, 10.1016/j.brainresbull.2006.09.019 · DOI
- Hargreaves, 1995, MK801-induced hyperactivity: Duration of effects in rats, Pharmacol Biochem Behav, 51, 13, 10.1016/0091-3057(94)00321-9 · DOI
- Barbaccia, 1986, Maprotiline: An antidepressant with an unusual pharmacological profile, J Pharmacol Exp Ther, 236, 307, 10.1016/S0022-3565(25)38881-6 · DOI · Paper page
- Andersen, 1989, The dopamine inhibitor GBR 12909: selectivity and molecular mechanism of action, Eur J Pharmacol, 166, 493, 10.1016/0014-2999(89)90363-4 · DOI · Paper page
- Cambridge, 1977, Prazosin, a selective antagonist of post-synaptic alpha-adrenoceptors, Br J Pharmacol, 59, 514
- Hamano, 2007, The alpha2-adrenergic receptor antagonist yohimbine improves endotoxin-induced inhibition of gastrointestinal motility in mice, Br J Anaesth, 98, 484, 10.1093/bja/aem011 · DOI
- Alburges, 1992, D1-receptor antagonists: Comparison of [3H]SCH39166 to [3H]SCH23390, J Chem Neuroanat, 5, 357, 10.1016/0891-0618(92)90051-Q · DOI
- Anderson, 2006, Administration of the D2 dopamine receptor antagonist sulpiride into the shell, but not the core, of the nucleus accumbens attenuates cocaine priming-induced reinstatement of drug seeking, Neuropsychopharmacology, 31, 1452, 10.1038/sj.npp.1300922 · DOI
- Jahn, 2006, SNAREs—engines for membrane fusion, Nat Rev Mol Cell Biol, 7, 631, 10.1038/nrm2002 · DOI · Paper page
- Cheng, 2013, SNARE proteins are essential in the potentiation of NMDA receptors by group II metabotropic glutamate receptors, J Physiol, 591, 3935, 10.1113/jphysiol.2013.255075 · DOI · Paper page
- Aarts, 2002, Treatment of ischemic brain damage by perturbing NMDA receptor-PSD-95 protein interactions, Science, 298, 846, 10.1126/science.1072873 · DOI · Paper page
- Jahn, 2012, Molecular machines governing exocytosis of synaptic vesicles, Nature, 490, 201, 10.1038/nature11320 · DOI · Paper page
- Lavaur, 2009, The membrane cytoskeletal protein adducin is phosphorylated by protein kinase C in D1 neurons of the nucleus accumbens and dorsal striatum following cocaine administration, J Neurochem, 111, 1129, 10.1111/j.1471-4159.2009.06405.x · DOI
- Urban, 2013, Treatment with a clinically-relevant dose of methylphenidate alters NMDA receptor composition and synaptic plasticity in the juvenile rat prefrontal cortex, Neurobiol Learn Mem, 101, 65, 10.1016/j.nlm.2013.01.004 · DOI · Paper page
- Steinpreis, 1996, The behavioral and neurochemical effects of phencyclidine in humans and animals: Some implications for modeling psychosis, Behav Brain Res, 74, 45, 10.1016/0166-4328(95)00162-X · DOI · Paper page
- Eshleman, 1999, Characteristics of drug interactions with recombinant biogenic amine transporters expressed in the same cell type, J Pharmacol Exp Ther, 289, 877, 10.1016/S0022-3565(24)38214-X · DOI · Paper page
- Berridge, 2012, Differential sensitivity to psychostimulants across prefrontal cognitive tasks: differential involvement of noradrenergic α1- and α2-receptors, Biol Psychiatry, 71, 467, 10.1016/j.biopsych.2011.07.022 · DOI · Paper page
- Schwab, 2001, Calcium-dependent translocation of synaptotagmin to the plasma membrane in the dendrites of developing neurones, Mol Brain Res, 96, 1, 10.1016/S0169-328X(01)00244-3 · DOI
- Thompson, 1998, Altered levels of the synaptosomal associated protein SNAP-25 in schizophrenia, Biol Psychiatry, 43, 239, 10.1016/S0006-3223(97)00204-7 · DOI
- Barr, 2000, Identification of DNA variants in the SNAP-25 gene and linkage study of these polymorphisms and attention-deficit hyperactivity disorder, Mol Psychiatry, 5, 405, 10.1038/sj.mp.4000733 · DOI · Paper page
- Etain, 2010, A SNAP25 promoter variant is associated with early-onset bipolar disorder and a high expression level in brain, Mol Psychiatry, 15, 748, 10.1038/mp.2008.148 · DOI
- Wilson, 2000, Coloboma mouse mutant as an animal model of hyperkinesis and attention deficit hyperactivity disorder, Neurosci Biobehav Rev, 24, 51, 10.1016/S0149-7634(99)00064-0 · DOI
- Zehle, 2007, Methylphenidate treatment recovers stress-induced elevated dendritic spine densities in the rodent dorsal anterior cingulate cortex, Dev Neurobiol, 67, 1891, 10.1002/dneu.20543 · DOI · Paper page
- De Kloet, 2005, Stress and the brain: From adaptation to disease, Nat Rev Neurosci, 6, 463, 10.1038/nrn1683 · DOI · Paper page
- Wanchoo, 2009, Descending glutamatergic pathways of PFC are involved in acute and chronic action of methylphenidate, Brain Res, 1301, 68, 10.1016/j.brainres.2009.08.095 · DOI · Paper page
Cited by
Yan, Z., & Rein, B. (2022) · Molecular Psychiatry · doi:10.1038/s41380-021-01092-3 · Cited by 300
“The therapeutic actions of psychostimulant methylphenidate for ADHD involve the preferential increase of catecholamine neurotransmission within PFC [47] and dose-dependent, bi-directional regulation of PFC glutamate receptors [48].”
BackgroundSelf-citationOsimo, E. F., Beck, K., Reis Marques, T., & Howes, O. D. (2019) · Molecular Psychiatry · doi:10.1038/s41380-018-0041-5 · Cited by 268
The Cognition-Enhancing Effects of Psychostimulants Involve Direct Action in the Prefrontal Cortex
Spencer, R. C., Devilbiss, D. M., & Berridge, C. W. (2015) · Biological Psychiatry · doi:10.1016/j.biopsych.2014.09.013 · Cited by 164
“In the PFC, NMDA-receptor mediated excitatory postsynaptic currents (EPSCs) are potentiated by a cognition-enhancing dose of MPH, an action that involves D1 receptors (89–91).”
InfluentialMotaghinejad, M., Motevalian, M., Fatima, S., Beiranvand, T., & Mozaffari, S. (2017) · Journal of Neural Transmission · doi:10.1007/s00702-017-1771-2 · Cited by 57
Ebrahimzadeh, A., Moghadam, S. Y., Rahimi, H., Motaghinejad, M., Motevalian, M., Safari, S., & Mesrabadi, M. A. (2020) · Acta Neurobiologiae Experimentalis · doi:10.21307/ane-2019-033 · Cited by 30
Metadata
- Authors
- Cheng, J., Xiong, Z., Duffney, L. J., Wei, J., Liu, A., Liu, S., Chen, G.-J., & Yan, Z.
- Venue
- Biological Psychiatry
- Publisher
- Elsevier BV
- Published
- 2014-12
- Volume
- 76
- Issue
- 12
- Pages
- 953-962
- ISSN
- 0006-3223 (ISSN-L)
- OpenAlex
- W2012090610
- Cited by
- 75
- References
- 18
- FWCI
- 3.35
- Type
- journal article
- Language
- en
- Open access
- bronze
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Funders
- National Institutes of Health (DA037618, MH085774, MH101690)
- National Natural Science Foundation of China (81220108010, 81171197)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Methylphenidate Exerts Dose-Dependent Effects on Glutamate Receptors and Behaviors. https://app.cochat.ai/papers/10.1016/j.biopsych.2014.04.003
- The paper
- Cheng, J., Xiong, Z., Duffney, L. J., Wei, J., Liu, A., Liu, S., Chen, G.-J., & Yan, Z. (2014). Methylphenidate Exerts Dose-Dependent Effects on Glutamate Receptors and Behaviors. Biological Psychiatry. https://doi.org/10.1016/j.biopsych.2014.04.003
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.